全文获取类型
收费全文 | 36613篇 |
免费 | 2208篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 324篇 |
儿科学 | 1175篇 |
妇产科学 | 1015篇 |
基础医学 | 4970篇 |
口腔科学 | 616篇 |
临床医学 | 5955篇 |
内科学 | 6670篇 |
皮肤病学 | 618篇 |
神经病学 | 3453篇 |
特种医学 | 610篇 |
外科学 | 3262篇 |
综合类 | 407篇 |
一般理论 | 55篇 |
预防医学 | 4549篇 |
眼科学 | 490篇 |
药学 | 2136篇 |
中国医学 | 68篇 |
肿瘤学 | 2562篇 |
出版年
2023年 | 197篇 |
2022年 | 387篇 |
2021年 | 779篇 |
2020年 | 462篇 |
2019年 | 783篇 |
2018年 | 906篇 |
2017年 | 625篇 |
2016年 | 653篇 |
2015年 | 841篇 |
2014年 | 1183篇 |
2013年 | 1802篇 |
2012年 | 2676篇 |
2011年 | 2825篇 |
2010年 | 1537篇 |
2009年 | 1298篇 |
2008年 | 2558篇 |
2007年 | 2571篇 |
2006年 | 2581篇 |
2005年 | 2413篇 |
2004年 | 2330篇 |
2003年 | 2209篇 |
2002年 | 2053篇 |
2001年 | 235篇 |
2000年 | 166篇 |
1999年 | 316篇 |
1998年 | 415篇 |
1997年 | 369篇 |
1996年 | 327篇 |
1995年 | 281篇 |
1994年 | 271篇 |
1993年 | 253篇 |
1992年 | 169篇 |
1991年 | 145篇 |
1990年 | 138篇 |
1989年 | 134篇 |
1988年 | 111篇 |
1987年 | 119篇 |
1986年 | 94篇 |
1985年 | 112篇 |
1984年 | 156篇 |
1983年 | 160篇 |
1982年 | 195篇 |
1981年 | 167篇 |
1980年 | 159篇 |
1979年 | 96篇 |
1978年 | 75篇 |
1977年 | 81篇 |
1976年 | 60篇 |
1975年 | 53篇 |
1974年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
Emeline Colomba Patricia Pautier Fanny Pommeret Alexandra Leary 《Expert review of anticancer therapy》2019,19(6):437-446
Introduction: The landscape of poly (ADP-ribose) polymerase (PARP) inhibition in ovarian cancer is rapidly evolving and becoming increasingly complex. Ovarian cancer is leading therapeutic innovation by providing the proof of concept for DNA repair as a target. Three different PARP inhibitors have now received approvals in the US and Europe in different indications. Subtle but crucial differences can be found among the licensed indications for each PARP inhibitor in terms of histology, type of BRCA mutation (germline and/or somatic), number of prior lines of chemotherapy and whether the indication is in the treatment or maintenance settings.
Areas covered: We review the latest clinical data regarding the PARP inhibitor rucaparib in ovarian cancer, provide an update on the evolving landscape of PARP inhibition in ovarian cancer, and summarize avenues of ongoing and future research.
Expert opinion: All eligible patients should be offered a PARP inhibitor. SOLO1 trial results demonstrated an unprecedented benefit maintenance with PARP inhibitors in first line. Results from trials evaluating PARP inhibitors as maintenance in first line regardless of BRCA status and from trials evaluating combinatorial strategies are eagerly awaited. 相似文献
2.
3.
Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: a focus group study 下载免费PDF全文
4.
Rebecca Wright Caleb Ferguson Mustafa Bodrick Hanan Balkhy Debra Jackson Patricia M. Davidson 《Journal of clinical nursing》2020,29(13-14):2723-2729
5.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
6.
7.
8.
Luis Miguel Azogil-López Juan José Pérez-Lázaro Patricia Ávila-Pecci Esther María Medrano-Sánchez María Valle Coronado-Vázquez 《Atencion primaria / Sociedad Espa?ola de Medicina de Familia y Comunitaria》2019,51(5):278-284
Aim
The purpose of this study is to find out whether telephone referral from Primary Health Care to Internal Medicine Consult manages to reduce waiting days as compared to traditional referral. This study also aims to know how acceptable is the telephone referral to general practitioners and their patients.Design
No blind randomized controlled clinical trial.Setting
Northern Huelva Health District.Participants
154 patients.Interventions
Patients referrals from intervention clinicians were sent via telephone consultation, whereas patients referrals from control clinicians were sent by traditional via.Measurements
Number of days from referral request to Internal Medicine Consult. Number of telephone and traditional referrals. Number of doctors and patients denied. Denial reasons.Results
A statistically significant difference was found between groups, with an average of 27 (21-34) days. Among General Practitioners, 8 of the first 58 total doctors after randomization and, subsequently, 6 of the 20 doctors of the test group refused to engage in the trial because they considered “excessive time and effort consuming”. 50% of patients referred by the 14 General Practitioners finally randomized to the intervention group were denied referral by telephone due to patient's complexity.Conclusions
Telephone referral significantly reduces waiting days for Internal Medicine consult. This type of referral did not mean an “excessive time and effort consuming” to General Practitioners and was not all that beneficial to complex patients 相似文献9.
Fluid role boundaries: exploring the contribution of the advanced nurse practitioner to multi‐professional palliative care 下载免费PDF全文
10.